Lead Product(s): Human embryonic stem cells
Therapeutic Area: Oncology Product Name: Undisclosed
Highest Development Status: Undisclosed Product Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: NRC IRAP
Deal Size: $0.4 million Upfront Cash: Undisclosed
Deal Type: Funding April 07, 2020
Support from NRC IRAP will go toward the research and development of a two-step safety switch known as panKiller.